NMDAR,CSF

Laura Marmolejo1, Claudia Papi1,2, Chiara Milano1,3

  • 1Neuroimmunology Program, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomédiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Spain and Caixa Research Institute (CRI), Barcelona, Spain.

Annals of neurology
|February 18, 2026
PubMed
概括

在抗N-甲基-D-酸盐受体脑炎 (NMDARe) 患者的脑脊液 (CSF) 中的Fc-糖化是分区和触发器特定的. 改变的甘氨酸样本与疾病的严重程度和结果相关,这表明它有可能作为预后生物标志物.